Print this Content
Email this Content

Appointed: 1987

Gene Barnett, M.D.

Gene Barnett, M.D.

Department: Brain Tumor and Neuro-Oncology Center
Director, Cleveland Clinic Gamma Knife Center
Location: Cleveland Clinic Main Campus
Mail Code R20
9500 Euclid Avenue
Cleveland, OH 44195
WorkPhone:(216) 444-5381

Gene Barnett, M.D.

Department: Taussig Cancer Institute
Location: Cleveland Clinic Main Campus
Mail Code R20
9500 Euclid Avenue
Cleveland, OH 44195
WorkPhone:(216) 444-5381

Biographical Sketch

Gene H. Barnett, MD, is Director of Cleveland Clinic’s Brain Tumor and Neuro-Oncology Center; Director of the Cleveland Clinic Health System Gamma Knife Center; and Vice-Chairman of the Department of Neurological Surgery. He has served on the Board of Governors of Cleveland Clinic for a five-year term and was President of the Staff.

He has authored more than 180 articles published in leading medical journals and has a particular interest in the areas of neuro-oncology, computer-assisted surgery and stereotactic radiosurgery. In the late 1980s, Dr. Barnett created the Center for Computer-Assisted Neurosurgery at Cleveland Clinic, which established Cleveland Clinic's neurosurgery program as an innovator in following:

  • Advanced stereotaxis, or the identification of discreet areas of the brain that control specific functions
  • Computer applications resulting in the creation of a powerful surgical navigation system called frameless stereotaxy.

He holds several patents in these areas and continues work on the development of robotics in neurosurgery, laser lesioning systems for brain tumors and next-generation surgical navigation systems.

Dr. Barnett is the past-president of the Ohio State Neurosurgical Society, and the Northeast Ohio Neurosurgical Society. He is a state representative for the Joint Council of State Neurosurgical Societies, and he has served as Chairman of its Northwest Quadrant. He also serves on the Executive Committee of the Section on Tumors and has been on the Board of Directors of the Joint Section of Stereotactic and Functional Neurosurgery and Board of Directors of the American Association of Neurological Surgeons. In addition, he is on the editorial boards of Neurosurgery, Journal of Image Guided Surgery and Select Reviews in Neuro-Oncology. He also is a reviewer for several neurosurgery journals.

He received his degree from Case Western Reserve University School of Medicine in Cleveland, completed his residency at the Cleveland Clinic Department of Neurosurgery and his fellowship in Neurosurgery at Massachusetts General Hospital in Boston, where he was a clinical and research fellow at the Harvard Medical School and Massachusetts General Hospital.

Professional Highlights

  • Rose Ella Burkhardt Chair in Brain Tumor Research
  • Mahaley Clinical Brain Tumor Research Award

Education & Fellowships

Other - Karolinska Gamma Knife Center
Gamma Knife

1996
Fellowship - Massachusetts General Hospital
Neurosurgical Surgery
Boston, MA USA
1987
Residency - Cleveland Clinic
Neurological Surgery
Cleveland, OH USA
1986
Internship - Cleveland Clinic
General Surgery
Cleveland, OH USA
1981
Medical School - Case Western Reserve University School of Medicine
Cleveland, OH USA
1980
Undergraduate - Case Western Reserve University
Biology and Chemistry
Cleveland, OH USA
1976

Certifications

  • Neurological Surgery

Specialty Interests

benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, gamma knife, gamma knife and radiosurgery, Gamma Knife Radiosurgery, Meningiomas, molecular biology of brain tumors clinical and translational trials, stereotactic surgery, Trigeminal Neuralgia, tumors of the brain and spine

Awards & Honors

  • Best Doctors in America
  • Top Docs
  • Mahaley Clinical Brain Tumor Research Award

Innovations & Patents

  • Multiple patents in the field of surgical navigation allowing for better, safer brain tumor surgery
  • Patent involving the use of a blood marker to detect presence or progression of brain tumors

Treatment & Services

  • Balloon Compression for Trigeminal Neuralgia
  • Brain Biopsy
  • Brain Tumor Diagnosis
  • Brain Tumor Management
  • Brain Tumor Surgery
  • Clinical Trials
  • Cranial Radiosurgery
  • Craniotomy for Brain Tumor
  • Gamma Knife Radiosurgery
  • Gamma Knife Treatment
  • High Risk Pregnancy Care
  • Lumbar Puncture (Spinal Tap)
  • Microvascular Decompression
  • Minimally Invasive Surgery
  • Neurosurgery
  • Novalis Radiosurgery/Radiotherapy
  • Radiation Therapy
  • Stereotactic Brain Biopsy
  • Stereotactic Radiosurgery
  • Stereotactic Surgery

Specialty in Diseases and Conditions

  • Acoustic Neuroma
  • Anaplastic Astrocytomas
  • Anaplastic Oligodendrogliomas
  • Astrocytoma
  • Benign Brain Tumors
  • Benign Tumors of the Brain
  • Benign Tumors of the Spinal Cord
  • Brain Cancer (Brain Tumor)
  • Brain Lymphoma
  • Brain Metastases
  • Cavernous Sinus Tumors
  • Chordomas
  • Clival Chordomas
  • Ependymomas
  • Glioblastoma Multiforme
  • Hemangioblastomas
  • Malignant Gliomas
  • Malignant Tumors of the Brain
  • Malignant Tumors of the Spinal Cord
  • Meningioma
  • Metastatic Cancer
  • Oligodendroglioma
  • Pituitary Tumors
  • Primary Central Nervous System Lymphomas
  • Sarcomas of the Brain or Head
  • Schwannoma
  • Trigeminal Neuralgia
  • Von Hippel-Lindau Disease (VHL)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Barnett has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting. Dr. Barnett receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

Elektra Instrument, AB

Monteris Medical Inc.

Inventor Share. Dr. Barnett may receive future financial benefits from the Cleveland Clinic for inventions or discoveries related to the companies shown below:

IntElect Medical, Inc.

Royalty Payments. Dr. Barnett has the right to receive royalty payments for inventions or discoveries related to the companies shown below:

Mako Surgical

Languages Spoken

  • English